- call +1-201-465-4211
- email sales@mrinsights.biz
Addison disease occurs due to the injury of the adrenal cortex which causes insufficient generation of the hormone aldosterone and cortisol.Indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone.
Scope of the Report:
This report focuses on the Addison Disease Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Treatment options for Addison's disease include many medications, usually in the form of tablets, depending on the specific hormones that the body is missing.
The drugs required to effectively treat Addison's depends on the hormones that are no longer being effectively produced in the adrenal glands.
The worldwide market for Addison Disease Testing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
NHS.UK
Mayo Clinic
VCA Animal Hospital
NIDDK
Cleveland Clinic
WebMD
BMJ Best Practice
National Organization for Rare Disorders
Core Diagnostics Private Limited
Laboratory Corporation of America Holdings
Sonora Quest Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Laboratory testing
Imaging studies
Market Segment by Applications, can be divided into
Clinics
Hospitals
Diagnostics laboratories
There are 15 Chapters to deeply display the global Addison Disease Testing market.
Chapter 1, to describe Addison Disease Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Addison Disease Testing, with sales, revenue, and price of Addison Disease Testing, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Addison Disease Testing, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Addison Disease Testing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Addison Disease Testing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Addison Disease Testing Introduction
1.2 Market Analysis by Type
1.2.1 Laboratory testing
1.2.2 Imaging studies
1.3 Market Analysis by Applications
1.3.1 Clinics
1.3.2 Hospitals
1.3.3 Diagnostics laboratories
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 NHS.UK
2.1.1 Business Overview
2.1.2 Addison Disease Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 NHS.UK Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mayo Clinic
2.2.1 Business Overview
2.2.2 Addison Disease Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mayo Clinic Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 VCA Animal Hospital
2.3.1 Business Overview
2.3.2 Addison Disease Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 VCA Animal Hospital Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 NIDDK
2.4.1 Business Overview
2.4.2 Addison Disease Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 NIDDK Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cleveland Clinic
2.5.1 Business Overview
2.5.2 Addison Disease Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cleveland Clinic Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 WebMD
2.6.1 Business Overview
2.6.2 Addison Disease Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 WebMD Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 BMJ Best Practice
2.7.1 Business Overview
2.7.2 Addison Disease Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BMJ Best Practice Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 National Organization for Rare Disorders
2.8.1 Business Overview
2.8.2 Addison Disease Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 National Organization for Rare Disorders Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Core Diagnostics Private Limited
2.9.1 Business Overview
2.9.2 Addison Disease Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Core Diagnostics Private Limited Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Laboratory Corporation of America Holdings
2.10.1 Business Overview
2.10.2 Addison Disease Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Laboratory Corporation of America Holdings Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sonora Quest Laboratories
2.11.1 Business Overview
2.11.2 Addison Disease Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sonora Quest Laboratories Addison Disease Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Addison Disease Testing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Addison Disease Testing Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Addison Disease Testing Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Addison Disease Testing Manufacturer Market Share in 2017
3.3.2 Top 6 Addison Disease Testing Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Addison Disease Testing Market Analysis by Regions
4.1 Global Addison Disease Testing Sales, Revenue and Market Share by Regions
4.1.1 Global Addison Disease Testing Sales and Market Share by Regions (2013-2018)
4.1.2 Global Addison Disease Testing Revenue and Market Share by Regions (2013-2018)
4.2 North America Addison Disease Testing Sales and Growth Rate (2013-2018)
4.3 Europe Addison Disease Testing Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Addison Disease Testing Sales and Growth Rate (2013-2018)
4.5 South America Addison Disease Testing Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Addison Disease Testing Sales and Growth Rate (2013-2018)
5 North America Addison Disease Testing by Countries
5.1 North America Addison Disease Testing Sales, Revenue and Market Share by Countries
5.1.1 North America Addison Disease Testing Sales and Market Share by Countries (2013-2018)
5.1.2 North America Addison Disease Testing Revenue and Market Share by Countries (2013-2018)
5.2 United States Addison Disease Testing Sales and Growth Rate (2013-2018)
5.3 Canada Addison Disease Testing Sales and Growth Rate (2013-2018)
5.4 Mexico Addison Disease Testing Sales and Growth Rate (2013-2018)
6 Europe Addison Disease Testing by Countries
6.1 Europe Addison Disease Testing Sales, Revenue and Market Share by Countries
6.1.1 Europe Addison Disease Testing Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Addison Disease Testing Revenue and Market Share by Countries (2013-2018)
6.2 Germany Addison Disease Testing Sales and Growth Rate (2013-2018)
6.3 UK Addison Disease Testing Sales and Growth Rate (2013-2018)
6.4 France Addison Disease Testing Sales and Growth Rate (2013-2018)
6.5 Russia Addison Disease Testing Sales and Growth Rate (2013-2018)
6.6 Italy Addison Disease Testing Sales and Growth Rate (2013-2018)
7 Asia-Pacific Addison Disease Testing by Countries
7.1 Asia-Pacific Addison Disease Testing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Addison Disease Testing Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Addison Disease Testing Revenue and Market Share by Countries (2013-2018)
7.2 China Addison Disease Testing Sales and Growth Rate (2013-2018)
7.3 Japan Addison Disease Testing Sales and Growth Rate (2013-2018)
7.4 Korea Addison Disease Testing Sales and Growth Rate (2013-2018)
7.5 India Addison Disease Testing Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Addison Disease Testing Sales and Growth Rate (2013-2018)
8 South America Addison Disease Testing by Countries
8.1 South America Addison Disease Testing Sales, Revenue and Market Share by Countries
8.1.1 South America Addison Disease Testing Sales and Market Share by Countries (2013-2018)
8.1.2 South America Addison Disease Testing Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Addison Disease Testing Sales and Growth Rate (2013-2018)
8.3 Argentina Addison Disease Testing Sales and Growth Rate (2013-2018)
8.4 Colombia Addison Disease Testing Sales and Growth Rate (2013-2018)
9 Middle East and Africa Addison Disease Testing by Countries
9.1 Middle East and Africa Addison Disease Testing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Addison Disease Testing Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Addison Disease Testing Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Addison Disease Testing Sales and Growth Rate (2013-2018)
9.3 UAE Addison Disease Testing Sales and Growth Rate (2013-2018)
9.4 Egypt Addison Disease Testing Sales and Growth Rate (2013-2018)
9.5 Nigeria Addison Disease Testing Sales and Growth Rate (2013-2018)
9.6 South Africa Addison Disease Testing Sales and Growth Rate (2013-2018)
10 Global Addison Disease Testing Market Segment by Type
10.1 Global Addison Disease Testing Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Addison Disease Testing Sales and Market Share by Type (2013-2018)
10.1.2 Global Addison Disease Testing Revenue and Market Share by Type (2013-2018)
10.2 Laboratory testing Sales Growth and Price
10.2.1 Global Laboratory testing Sales Growth (2013-2018)
10.2.2 Global Laboratory testing Price (2013-2018)
10.3 Imaging studies Sales Growth and Price
10.3.1 Global Imaging studies Sales Growth (2013-2018)
10.3.2 Global Imaging studies Price (2013-2018)
11 Global Addison Disease Testing Market Segment by Application
11.1 Global Addison Disease Testing Sales Market Share by Application (2013-2018)
11.2 Clinics Sales Growth (2013-2018)
11.3 Hospitals Sales Growth (2013-2018)
11.4 Diagnostics laboratories Sales Growth (2013-2018)
12 Addison Disease Testing Market Forecast (2018-2023)
12.1 Global Addison Disease Testing Sales, Revenue and Growth Rate (2018-2023)
12.2 Addison Disease Testing Market Forecast by Regions (2018-2023)
12.2.1 North America Addison Disease Testing Market Forecast (2018-2023)
12.2.2 Europe Addison Disease Testing Market Forecast (2018-2023)
12.2.3 Asia-Pacific Addison Disease Testing Market Forecast (2018-2023)
12.2.4 South America Addison Disease Testing Market Forecast (2018-2023)
12.2.5 Middle East and Africa Addison Disease Testing Market Forecast (2018-2023)
12.3 Addison Disease Testing Market Forecast by Type (2018-2023)
12.3.1 Global Addison Disease Testing Sales Forecast by Type (2018-2023)
12.3.2 Global Addison Disease Testing Market Share Forecast by Type (2018-2023)
12.4 Addison Disease Testing Market Forecast by Application (2018-2023)
12.4.1 Global Addison Disease Testing Sales Forecast by Application (2018-2023)
12.4.2 Global Addison Disease Testing Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Addison Disease Testing Picture
Table Product Specifications of Addison Disease Testing
Figure Global Sales Market Share of Addison Disease Testing by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
